ArticleThe Australian journal of rural health2026
Community Perspectives on Japanese Encephalitis Risk and Prevention in an Endemic Region of Australia.
Article in The Australian journal of rural health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveJapanese encephalitis (JE) is a mosquito-borne disease caused by JE virus (JEV) infection, detected for the first time in south-eastern Australia in 2022. In New South Wales (NSW), detections of JEV in mosquitoes and animal hosts, human JE cases, and climate and environmental considerations have informed which areas are considered high risk for JEV and which populations are eligible for vaccination (funded by Australian states and territories). However, early evidence indicates slower-than-expected uptake in these high-risk areas. We aimed to explore how community members and healthcare professionals (HCPs), including general practitioners (GPs), pharmacists, and nurses, perceive and have responded to JEV risk through vaccination and personal mosquito-bite prevention practices.
settingTamworth is classified as high-risk for JEV by NSW Health.
participantsSemi-structured interviews with community participants (n = 15), GPs (n = 7), nurses (n = 3), and pharmacists (n = 3).
designAn interpretative qualitative study. Data were analysed using an inductive thematic approach.
resultsThree themes were identified: (1) Risk awareness shaped by experience, not policy: "I didn't realise Tamworth was identified as an area as well, I just was totally unaware," (2) Vaccine eligibility does not translate into uptake: "There isn't really much promotion at the moment," and (3) Building community-level preparedness through communication: "Messaging that the whole community knows about."
conclusionDespite early public health efforts, awareness of JE and uptake of preventive measures remained limited in a high-risk regional setting. Supporting trusted healthcare providers with clear, consistent communication is critical to optimising JE vaccine uptake.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.